Milestone Pharmaceuticals

MIST

Market cap $157M

1.85 USD

+0.14

8.19%

At close Updated Nov 10, 4:00 PM EST

Pre-market

After hours

1.86

+0.01

0.54%

1 day

8.19%

5 days

1.65%

1 month

-7.04%

3 months

19.35%

6 months

54.17%

Year to date

-14.75%

1 year

-4.64%

5 years

-70.26%

10 years

-87.96%

About: Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Employees: 33

Healthcare Biotechnology